Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2007-02-01 (19 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: GRESY-SUR-AIX (73100), Savoie
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DES CASCADES : revenue, balance sheet and financial ratios
PHARMACIE DES CASCADES is a French company
founded 19 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in GRESY-SUR-AIX (73100),
this company of category PME
shows in 2025 a net income positive of 313 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DES CASCADES (SIREN 493789838)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
312 924 €
86 496 €
44 601 €
433 506 €
283 515 €
201 753 €
201 209 €
206 656 €
100 214 €
227 436 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE DES CASCADES generates positive net income of 313 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 227 k€ -> 313 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
312 924 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 28%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 62%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
28.474%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
62.073%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DES CASCADES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
39.245
30.791
16.659
8.059
6.083
6.147
5.121
21.876
22.823
28.474
Financial autonomy
63.799
68.074
74.354
79.901
82.754
79.277
78.451
68.433
66.067
62.073
Repayment capacity
None
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
28.472025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Good+9 pts over 3 years
In 2025, the debt ratio of PHARMACIE DES CASCADES (28.47) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
62.07%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Good-14 pts over 3 years
In 2025, the financial autonomy of PHARMACIE DES CASCADES (62.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 175.19. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
175.186
Liquidity indicators evolution PHARMACIE DES CASCADES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
193.724
169.43
152.903
170.896
233.625
237.553
250.866
212.417
216.493
175.186
Interest coverage
None
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
175.192025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Average-10 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE DES CASCADES (175.19) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of PHARMACIE DES CASCADES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DES CASCADES is estimated at
4 970 834 €
(range 3 373 232€ - 7 799 924€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
3373k€4970k€7799k€
4 970 834 €Range: 3 373 232€ - 7 799 924€
NAF 5 année 2025
Valuation method used
Net Income Multiple
312 924 €
×
15.9x
=4 970 835 €
Range: 3 373 232€ - 7 799 925€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DES CASCADES with other companies in the same sector:
Frequently asked questions about PHARMACIE DES CASCADES
What is the revenue of PHARMACIE DES CASCADES ?
The revenue of PHARMACIE DES CASCADES is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DES CASCADES profitable?
Yes, PHARMACIE DES CASCADES generated a net profit of 313 k€ in 2025.
Where is the headquarters of PHARMACIE DES CASCADES ?
The headquarters of PHARMACIE DES CASCADES is located in GRESY-SUR-AIX (73100), in the department Savoie.
Where to find the tax return of PHARMACIE DES CASCADES ?
The tax return of PHARMACIE DES CASCADES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DES CASCADES operate?
PHARMACIE DES CASCADES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart